REGENERON PHARMACEUTICALS, INC.: accounts_receivable
| Value | {"amount": 703857000, "concept": "us-gaap:AccountsReceivableNetCurrent", "currency": "USD"} |
|---|---|
| Period | (as of 2013-03-31) |
| Status | current |
| Entity | REGENERON PHARMACEUTICALS, INC. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T08:39:06.709867+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/f62666f6-b58e-4e48-a8c7-b7aa9bd7f2c8
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001532176-13-000008Retrieved: 2026-08-19T08:39:06.709867+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0000872589/accounts-receivable/2013-03-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/f62666f6-b58e-4e48-a8c7-b7aa9bd7f2c8
History
- no predecessors — first report